Cytek Biosciences (CTKB) Research & Development (2020 - 2026)

Cytek Biosciences' Research & Development history runs 7 years deep, the most recent figure standing at $9.6 million for Q1 2026.

• Quarterly Research & Development fell 1.24% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.5 million (up 3.02% YoY) and the FY2025 annual result came in at $49.4 million, up 25.48% from the prior year.
• Research & Development was $9.6 million for Q1 2026 at Cytek Biosciences, down from $13.1 million in the prior quarter.
• Across five years, Research & Development topped out at $13.1 million in Q4 2025 and bottomed at $7.0 million in Q1 2022.
• A 5-year average of $10.1 million and a median of $9.7 million in 2022 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2023 — Research & Development surged 60.13% — and 2025, when it declined 22.47%.
• Cytek Biosciences' Research & Development stood at $9.7 million in 2022, then grew by 18.61% to $11.6 million in 2023, then decreased by 15.9% to $9.7 million in 2024, then jumped by 35.05% to $13.1 million in 2025, then fell by 26.86% to $9.6 million in 2026.
• Business Quant data shows CTKB's Research & Development at $9.6 million in Q1 2026, $13.1 million in Q4 2025, and $9.0 million in Q3 2025.